Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study.
Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, Kerr P, Chan C, Smith A, Steven N, Edwards C, Ashton-Key M, Hodges E, Tutt A, Ottensmeier C, Glennie M, Williams A.
Johnson P, et al.
Clin Cancer Res. 2015 Mar 15;21(6):1321-8. doi: 10.1158/1078-0432.CCR-14-2355. Epub 2015 Jan 14.
Clin Cancer Res. 2015.
PMID: 25589626
Clinical Trial.